Pfizer Inc. (PFE.F)
Develops and sells medicines to treat cancer, heart disease, infections, vaccines, and rare conditions
22.19+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+9.4%
The outlook
Pfizer is trading near the midpoint of its 52-week range with a mixed near-term trend against its moving averages. Analyst coverage shows a neutral lean, reflected in the stock's 48/100 StockGlow score. The trailing P/E of 19.3 sits at a moderate valuation level relative to recent history.
What’s behind the score
Price trendMixed vs its moving averages
52-week range45% of the way from its 52-week low to high
Market cap
$126.47B
52-wk high
24.86
52-wk low
20.00
50-day avg
21.86
200-day avg
22.25
Trailing P/E
19.3